Galaxy Diagnostics Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Series A3

  • Latest Deal Amount
  • $3.02M

  • Investors
  • 11

Galaxy Diagnostics General Information

Description

Developer of diagnostic tests for flea- and tick-borne diseases designed to improve the detection of vector-borne infections. The company's tests utilize direct detection methods, including molecular testing, antigen detection technologies, and urine-based antigen capture, providing healthcare providers with improved sensitivity for identifying infections such as Bartonella, Babesia, and Borrelia that are often missed by conventional testing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6 Davis Drive, Research Triangle Park
  • Suite 832
  • Durham, NC 27709
  • United States
+1 (919)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Laboratory Services (Healthcare)
Vertical(s)
Corporate Office
  • 6 Davis Drive, Research Triangle Park
  • Suite 832
  • Durham, NC 27709
  • United States
+1 (919)

Galaxy Diagnostics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Galaxy Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A3) 03-Jun-2026 $3.02M Completed Generating Revenue
7. Accelerator/Incubator 25-Feb-2026 Completed Generating Revenue
6. Later Stage VC (Series A) 12-Nov-2025 Completed Generating Revenue
5. Later Stage VC (Series A) 31-Jul-2024 Completed Generating Revenue
4. Later Stage VC (Series A1) 15-Aug-2014 Completed Startup
3. Debt - General 19-Dec-2012 Completed Startup
2. Debt - General 12-May-2009 $40K $40K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Galaxy Diagnostics’s complete valuation and funding history, request access »

Galaxy Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A4
Series A3
Series A2
Series A1 1,565,561 $0.32 $0.32 1x $0.32 5.01%
Series A 2,422,645 $1 $1 1x $1 7.75%
To view Galaxy Diagnostics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Galaxy Diagnostics Patents

Galaxy Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026151779-A1 Methods and systems for detecting a microorganism Pending 08-Jan-2025
US-20230123800-A1 Digital pcr assays for detection of pathogens Pending 15-Apr-2020
WO-2021211802-A1 Digital pcr assays for detection of pathogens Inactive 15-Apr-2020 C12Q1/689

Galaxy Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Galaxy Diagnostics Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Charleston Angel Partners Angel Group Minority
NW Angel Venture Capital Minority
Center For Entrepreneurial Development Accelerator/Incubator
NC Tweener Fund Venture Capital Minority
Wisconsin Investment Partners Angel Group Minority
You’re viewing 5 of 11 investors. Get the full list »

Galaxy Diagnostics FAQs

  • When was Galaxy Diagnostics founded?

    Galaxy Diagnostics was founded in 2009.

  • Where is Galaxy Diagnostics headquartered?

    Galaxy Diagnostics is headquartered in Durham, NC.

  • What is the size of Galaxy Diagnostics?

    Galaxy Diagnostics has 21 total employees.

  • What industry is Galaxy Diagnostics in?

    Galaxy Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Galaxy Diagnostics a private or public company?

    Galaxy Diagnostics is a Private company.

  • What is the current valuation of Galaxy Diagnostics?

    The current valuation of Galaxy Diagnostics is .

  • What is Galaxy Diagnostics’s current revenue?

    The current revenue for Galaxy Diagnostics is .

  • How much funding has Galaxy Diagnostics raised over time?

    Galaxy Diagnostics has raised $9.8M.

  • Who are Galaxy Diagnostics’s investors?

    Charleston Angel Partners, NW Angel, Center For Entrepreneurial Development, NC Tweener Fund, and Wisconsin Investment Partners are 5 of 11 investors who have invested in Galaxy Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process